Filing Details
- Accession Number:
- 0001628280-23-022218
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-15 16:05:11
- Reporting Period:
- 2023-06-13
- Accepted Time:
- 2023-06-15 16:05:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1685904 | Roger Adsett | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-06-13 | 8,981 | $19.32 | 151,352 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2023.
- This is the weighted average sales price representing 8,981 shares sold at prices ranging from $19.23 to $19.46 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.